Polo-like kinase 2, a novel ADAM17 signaling component, regulates tumor necrosis factor α ectodomain shedding

Journal of Biological Chemistry

Volumn 289, Issue 5, 2014, Pages 3080-3093

  Schwarz, Jeanette ^a   Schmidt, Stefanie ^a   Will, Olga ^b   Koudelka, Tomas ^c   Köhler, Kaja ^a   Boss, Melanie ^a   Rabe, Björn ^a   Tholey, Andreas ^c   Scheller, Jürgen ^a,d   Schmidt Arras, Dirk ^a   Schwake, Michael ^a,e   Rose John, Stefan ^a   Chalaris, Athena ^a  

^a Kiel and Lungen Clinic Grosshansdorf   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^d HEINRICH HEINE UNIVERSITY   (Germany)

^e BIELEFELD UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADAM ADAMTS; ADAM17; METALLOPROTEASE; PHOSPHORYLATION; PLK2; SHEDDING; TUMOR NECROSIS FACTOR (TNF);

ADAM PROTEINS; AMINO ACID SEQUENCE; ANIMALS; BONE MARROW CELLS; DENDRITIC CELLS; HEK293 CELLS; HUMANS; MACROPHAGES; MICE; MOLECULAR SEQUENCE DATA; NIH 3T3 CELLS; PHOSPHORYLATION; PROTEIN STRUCTURE, TERTIARY; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 84893474483     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.536847     Document Type: Article

References (64)

1. Fong, K. P., Barry, C, Tran, A. N, Traxler, E. A., Wannemacher, K. M., Tang, H. Y., Speicher, K. D., Blair, I. A., Speicher, D. W., Grosser, T., and Brass, L. F. (2011) Deciphering the human platelet sheddome. Blood 117, e15-e26
2. Blobel, C. P. (2005) ADAMs. Key components in EGFR signalling and development. Nat Rev. Mol. Cell Biol. 6, 32-43
3. Saftig, P., and Reiss, K. (2011) The "A Disintegrin And Metalloproteases" ADAM10 and ADAM17. Novel drug targets with therapeutic potential? Eur. J. Cell Biol. 90, 527-535
4. Black, R. A., Rauch, C. T., Kozlosky, C. J., Peschon, J. J., Slack, J. L., Wolfson, M. F., Castner, B. J., Stocking, K. L., Reddy, P., Srinivasan, S., Nelson, N, Boiani, N, Schooley, K. A., Gerhart, M., Davis, R., Fitzner, J. N, Johnson, R. S., Paxton, R. J., March, C. J., and Cerretti, D. P. (1997) A metalloproteinase disintegrin that releases tumour-necrosis factor-a from cells. Nature 385, 729-733
5. Moss, M. L., Jin, S. L., Milla, M. E., Bickett, D. M., Burkhart, W., Carter, H. L., Chen, W. J., Clay, W. C, Didsbury, J. R., Hassler, D., Hoffman, C. R., Kost, T. A., Lambert, M. H., Leesnitzer, M. A., McCauley, P., McGeehan, G., Mitchell, J., Moyer, M., Pahel, G., Rocque, W., Overton, L. K., Schoenen, F., Seaton, T., Su, J. L., and Becherer, J. D. (1997) Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-a. Nature 385, 733-736
6. Gooz, M. (2010) ADAM-17. The enzyme that does it all. Crit. Rev. Biochem. Mol. Biol. 45, 146-169
7. Scheller, J., Chalaris, A., Garbers, C, and Rose-John, S. (2011) ADAM17. A molecular switch to control inflammation and tissue regeneration. Trends Immunol. 32, 380-387
8. Peschon, J. J., Slack, J. L., Reddy, P., Stocking, K. L., Sunnarborg, S. W., Lee, D. C, Russell, W. E., Castner, B. J., Johnson, R. S., Fitzner, J. N, Boyce, R. W., Nelson, N, Kozlosky, C. J., Wolfson, M. F., Rauch, C. T., Cerretti, D. P., Paxton, R. J., March, C. J., and Black, R. A. (1998) An essential role for ectodomain shedding in mammalian development. Science 282, 1281-1284
9. Horiuchi, K., Kimura, T., Miyamoto, T., Takaishi, H., Okada, Y., Toyama, Y., and Blobel, C. P. (2007) Cutting edge. TNF-α-converting enzyme (TACE/ADAM17) inactivation in mouse myeloid cells prevents lethality from endotoxin shock. J. Immunol. 179, 2686-2689
10. Long, C, Wang, Y., Herrera, A. H., Horiuchi, K., and Walcheck, B. (2010) In vivo role of leukocyte ADAM17 in the inflammatory and host responses during E. coli-mediated peritonitis. J. Leukocyte Biol. 87, 1097-1101
11. Yoda, M., Kimura, T., Tohmonda, T., Morioka, H, Matsumoto, M., Okada, Y., Toyama, Y., and Horiuchi, K. (2013) Systemic overexpression of TNFa-converting enzyme does not lead to enhanced shedding activity in vivo. PLoS One 8, e54412
12. Le Gall, S. M., Maretzky, T., Issuree, P. D., Niu, X. D., Reiss, K., Saftig, P., Khokha, R., Lundell, D., and Blobel, C. P. (2010) ADAM17 is regulated by a rapid and reversible mechanism that controls access to its catalytic site. J. CellSci. 123, 3913-3922
13. Soond, S. M., Everson, B., Riches, D. W., and Murphy, G. (2005) ERK-mediated phosphorylation of Thr735 in TNFa-converting enzyme and its potential role in TACE protein trafficking. J. Cell Sci. 118, 2371-2380
14. Xu, P., Liu, J., Sakaki-Yumoto, M., and Derynck, R. (2012) TACE activation by MAPK-mediated regulation of cell surface dimerization and TIMP3 association. Sci. Signal. 5, ra34
15. Zhang, Q., Thomas, S. M., Lui, V. W., Xi, S., Siegfried, J. M., Fan, H, Smithgall, T. E., Mills, G. B., and Grandis, J. R. (2006) Phosphorylation of TNF-α converting enzyme by gastrin-releasing peptide induces amphiregulin release and EGF receptor activation. Proc. Natl. Acad. Sci. U. S. A. 103, 6901-6906
16. Chalaris, A., Rabe, B., Paliga, K., Lange, H, Laskay, T., Fielding, C. A., Jones, S. A., Rose-John, S., and Scheller, J. (2007) Apoptosis is a natural stimulus of IL6R shedding and contributes to the proinflammatory transsignaling function of neutrophils. Blood 110, 1748-1755
17. Chanthaphavong, R. S., Loughran, P. A., Lee, T. Y., Scott, M. J., and Billiar, T. R. (2012) A role for cGMP in inducible nitric-oxide synthase (iNOS) - induced tumor necrosis factor (TNF) a-converting enzyme (TACE/ADAM17) activation, translocation, and TNF receptor 1 (TNFR1) shedding in hepatocytes. J. Biol. Chem. 287, 35887-35898
18. Dang, M., Armbruster, N, Miller, M. A., Cermeno, E., Hartmann, M., Bell, G. W., Root, D. E., Lauffenburger, D. A., Lodish, H. F., and Herrlich, A. (2013) Regulated ADAM17-dependent EGF family ligand release by substrate-selecting signaling pathways. Proc. Natl. Acad. Sci. U. S. A. 110, 9776-9781
19. Díaz-Rodríguez, E., Montero, J. C, Esparís-Ogando, A., Yuste, L., and Pandiella, A. (2002) Extracellular signal-regulated kinase phosphorylates tumor necrosis factor a-converting enzyme at threonine 735. A potential role in regulated shedding. Mol. Biol. Cell 13, 2031-2044
20. Xu, P., and Derynck, R. (2010) Direct activation of TACE-mediated ectodomain shedding by p38 MAP kinase regulates EGF receptor-dependent cell proliferation. Mol. Cell 37, 551-566
21. Maretzky, T., Zhou, W., Huang, X. Y., and Blobel, C. P. (2011) A transforming Src mutant increases the bioavailability of EGFR ligands via stimulation of the cell-surface metalloproteinase ADAM17. Oncogene 30, 611-618
22. Reddy, P., Slack, J. L., Davis, R., Cerretti, D. P., Kozlosky, C. J., Blanton, R. A., Shows, D., Peschon, J. J., and Black, R. A. (2000) Functional analysis of the domain structure of tumor necrosis factor-a converting enzyme. J. Biol. Chem. 275, 14608-14614
23. Schwarz, J., Broder, C, Helmstetter, A., Schmidt, S., Yan, I., Müller, M., Schmidt-Arras, D., Becker-Pauly, C, Koch-Nolte, F., Mittrücker, H. W., Rabe, B., Rose-John, S., and Chalaris, A. (2013) Short-term TNFa shedding is independent of cytoplasmic phosphorylation or furin cleavage of ADAM17. Biochim. Biophys. Acta 1833, 3355-3367
24. Clay, F. J., McEwen, S. J., Bertoncello, I., Wilks, A. F., and Dunn, A. R. (1993) Identification and cloning of a protein kinase-encoding mouse gene, Plk, related to the polo gene of Drosophila. Proc. Natl. Acad. Sci. U. S. A. 90, 4882-4886
25. Sunkel, C. E., and Glover, D. M. (1988) polo, a mitotic mutant of Drosophila displaying abnormal spindle poles. J. Cell Sci. 89, 25-38
26. Cheng, K. Y., Lowe, E. D., Sinclair, J., Nigg, E. A., and Johnson, L. N (2003) The crystal structure of the human Polo-like kinase-1 Polo box domain and its phospho-peptide complex. EMBOJ. 22, 5757-5768
27. García-Alvarez, B., De Cárcer, G., Ibañez, S., Bragado-Nilsson, E., and Montoya, G. (2007) Molecular and structural basis of Polo-like kinase 1 substrate recognition. Implications in centrosomal localization. Proc. Natl. Acad. Sci. U. S. A. 104, 3107-3112
28. Kothe, M., Kohls, D., Low, S., Coli, R., Cheng, A. C, Jacques, S. L., Johnson, T. L., Lewis, C, Loh, C, Nonomiya, J., Sheils, A. L., Verdries, K. A., Wynn, T. A., Kuhn, C, and Ding, Y. H. (2007) Structure of the catalytic domain of human Polo-like kinase 1. Biochemistry 46, 5960-5971
29. Elia, A. E., Rellos, P., Haire, L. F., Chao, J. W., Ivins, F. J., Hoepker, K., Mohammad, D., Cantley, L. C, Smerdon, S. J., and Yaffe, M. B. (2003) The molecular basis for phosphodependent substrate targeting and regulation of Plks by the Polo-box domain. Cell 115, 83-95
30. Evers, D. M., Matta, J. A., Hoe, H. S., Zarkowsky, D., Lee, S. H, Isaac, J. T., and Pak, D. T. (2010) Plk2 attachment to NSF induces homeostatic removal of GluA2 during chronic overexcitation. Nat. Neurosci. 13, 1199-1207
31. Barr, F. A., Silljé, H. H., and Nigg, E. A. (2004) Polo-like kinases and the orchestration of cell division. Nat. Rev. Mol. Cell Biol. 5, 429-440
32. Petronczki, M., Lénárt, P., and Peters, J. M. (2008) Polo on the rise. From mitotic entry to cytokinesis with Plk1. Dev. Cell 14, 646-659
33. Shimizu-Yoshida, Y., Sugiyama, K., Rogounovitch, T., Ohtsuru, A., Namba, H., Saenko, V., and Yamashita, S. (2001) Radiation-inducible hSNK gene is transcriptionally regulated by p53 binding homology element in human thyroid cells. Biochem. Biophys. Res. Commun. 289, 491-498
34. Burns, T. F., Fei, P., Scata, K. A., Dicker, D. T., and El-Deiry, W. S. (2003) Silencing of the novel p53 target gene Snk/Plk2 leads to mitotic catastrophe in paclitaxel (taxol)-exposed cells. Mol. Cell Biol. 23, 5556-5571
35. Chevrier, N., Mertins, P., Artyomov, M. N., Shalek, A. K., Iannacone, M., Ciaccio, M. F., Gat-Viks, I., Tonti, E., De Grace, M. M., Clauser, K. R., Garber, M., Eisenhaure, T. M., Yosef, N., Robinson, J., Sutton, A., Andersen, M. S., Root, D. E., Von Andrian, U., Jones, R. B., Park, H., Carr, S. A., Regev, A., Amit, I., and Hacohen, N. (2011) Systematic discovery of TLR signaling components delineates viral-sensing circuits. Cell 147, 853-867
36. Rose-John, S. (2013) ADAM17, shedding, TACE as therapeutic targets. Pharmacol. Res. 71 C, 19-22
37. Suthaus, J., Tillmann, A., Lorenzen, I., Bulanova, E., Rose-John, S., and Scheller, J. (2010) Forced homo- and heterodimerization of all gp130-type receptor complexes leads to constitutive ligand-independent signaling and cytokine-independent growth. Mol. Biol. Cell 21, 2797-2807
38. Inaba, K., Inaba, M., Romani, N., Aya, H., Deguchi, M., Ikehara, S., Muramatsu, S., and Steinman, R. M. (1992) Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176, 1693-1702
39. Klug, K., Ehlers, S., Uhlig, S., and Reiling, N. (2011) Mitogen-activated protein kinases p38 and ERK1/2 regulated control of Mycobacterium avium replication in primary murine macrophages is independent of tumor necrosis factor-a and interleukin-10. Innate Immun. 17, 470-485
40. Cassonnet, P., Rolloy, C., Neveu, G., Vidalain, P. O., Chantier, T., Pellet, J., Jones, L., Muller, M., Demeret, C., Gaud, G., Vuillier, F., Lotteau, V., Tangy, F., Favre, M., and Jacob, Y. (2011) Benchmarking a luciferase complementation assay for detecting protein complexes. Nat. Meth. 8, 990-992
41. Lorenzen, I., Lokau, J., Düsterhöft, S., Trad, A., Garbers, C., Scheller, J., Rose-John, S., and Grötzinger, J. (2012) The membrane-proximal domain of A Disintegrin and Metalloprotease 17 (ADAM17) is responsible for recognition of the interleukin-6 receptor and interleukin-1 receptor II. FEBSLett. 586, 1093-1100
42. Lorenzen, I., Trad, A., and Grötzinger, J. (2011) Multimerisation of A disintegrin and metalloprotease protein-17 (ADAM17) is mediated by its EGF-like domain. Biochem. Biophys. Res. Commun. 415, 330-336
43. Seeburg, D. P., Feliu-Mojer, M., Gaiottino, J., Pak, D. T., and Sheng, M. (2008) Critical role of CDK5 and Polo-like kinase 2 in homeostatic synaptic plasticity during elevated activity. Neuron 58, 571-583
44. Elia, A. E., Cantley, L. C, and Yaffe, M. B. (2003) Proteomic screen finds pSer/pThr-binding domain localizing Plk1 to mitotic substrates. Science 299, 1228-1231
45. Leonard, J. D., Lin, F., and Milla, M. E. (2005) Chaperone-like properties of the prodomain of TNFa-converting enzyme (TACE) and the functional role of its cysteine switch. Biochem. J. 387, 797-805
46. Lee, K. J., Lee, Y., Rozeboom, A., Lee, J. Y., Udagawa, N., Hoe, H. S., and Pak, D. T. (2011) Requirement for Plk2 in orchestrated ras and rap signaling, homeostatic structural plasticity, and memory. Neuron 69, 957-973
47. Strebhardt, K. (2010) Multifaceted Polo-like kinases. Drug targets and antitargets for cancer therapy. Nat. Rev. Drug Discov. 9, 643-660
48. Chalaris, A., Adam, N., Sina, C, Rosenstiel, P., Lehmann-Koch, J., Schirmacher, P., Hartmann, D., Cichy, J., Gavrilova, O., Schreiber, S., Jostock, T., Matthews, V., Häsler, R., Becker, C, Neurath, M. F., Reiss, K., Saftig, P., Scheller, J., and Rose-John, S. (2010) Critical role of the disintegrin metalloprotease ADAM17 for intestinal inflammation and regeneration in mice. J. Exp. Med. 207, 1617-1624
49. La Marca, R., Cerri, F., Horiuchi, K., Bachi, A., Feltri, M. L., Wrabetz, L., Blobel, C. P., Quattrini, A., Salzer, J. L., and Taveggia, C. (2011) TACE (ADAM17) inhibits Schwann cell myelination. Nat. Neurosci. 14, 857-865
50. Archambault, V., and Glover, D. M. (2009) Polo-like kinases. Conservation and divergence in their functions and regulation. Nat. Rev. Mol. Cell Biol. 10, 265-275
51. Feldmann, M., and Maini, S. R. (2008) Role of cytokines in rheumatoid arthritis. An education in pathophysiology and therapeutics. Immunol. Rev. 223, 7-19
52. Mohler, K. M., Sleath, P. R., Fitzner, J. N., Cerretti, D. P., Alderson, M., Kerwar, S. S., Torrance, D. S., Otten-Evans, C, Greenstreet, T., and Weerawarna, K. (1994) Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing. Nature 370, 218-220
53. Schroder, K., and Tschopp, J. (2010) The inflammasomes. Cell 140, 821-832
54. Ma, S., Charron, J., and Erikson, R. L. (2003) Role of Plk2 (Snk) in mouse development and cell proliferation. Mol. Cell Biol. 23, 6936-6943
55. Rousseau, S., Papoutsopoulou, M., Symons, A., Cook, D., Lucocq, J. M., Prescott, A. R., O'Garra, A., Ley, S. C, and Cohen, P. (2008) TPL2-mediated activation of ERK1 and ERK2 regulates the processing of pre-TNF a in LPS-stimulated macrophages. J. CellSci. 121, 149-154
56. Scott, A. J., O'Dea, K. P., O'Callaghan, D., Williams, L., Dokpesi, J. O., Tatton, L., Handy, J. M., Hogg, P. J., and Takata, M. (2011) Reactive oxygen species and p38 mitogen-activated protein kinase mediate tumor necrosis factor a-converting enzyme (TACE/ADAM-17) activation in primary human monocytes. J. Biol. Chem. 286, 35466-35476
57. Mbefo, M. K., Paleologou, K. E., Boucharaba, A., Oueslati, A., Schell, H, Fournier, M., Olschewski, D., Yin, G., Zweckstetter, M., Masliah, E., Kahle, P. J., Hirling, H, and Lashuel, H. A. (2010) Phosphorylation of synucleins by members of the Polo-like kinase family. J. Biol. Chem. 285, 2807-2822
58. Salvi, M., Trashi, E., Cozza, G., Franchin, C, Arrigoni, G., and Pinna, L. A. (2012) Investigation on PLK2 and PLK3 substrate recognition. Biochim. Biophys. Acta 1824, 1366-1373
59. Van De Weerdt, B. C, Littler, D. R., Klompmaker, R., Huseinovic, A., Fish, A., Perrakis, A., and Medema, R. H. (2008) Polo-box domains confer target specificity to the Polo-like kinase family. Biochim. Biophys. Acta 1783, 1015-1022
60. Lee, K. S., Grenfell, T. Z., Yarm, F. R., and Erikson, R. L. (1998) Mutation of the Polo-box disrupts localization and mitotic functions of the mammalian Polo kinase Plk. Proc. Natl. Acad. Sci. U. S. A. 95, 9301-9306
61. Hall, K. C, and Blobel, C. P. (2012) Interleukin-1 stimulates ADAM17 through a mechanism independent of its cytoplasmic domain or phosphorylation at threonine 735. PLoS One 7, e31600
62. Maretzky, T., McIlwain, D. R., Issuree, P. D., Li, X., Malapeira, J., Amin, S., Lang, P. A., Mak, T. W., and Blobel, C. P. (2013) iRhom2 controls the substrate selectivity of stimulated ADAM17-dependent ectodomain shedding. Proc. Natl. Acad. Sci. U. S. A. 110, 11433-11438
63. Mross, K., Frost, A., Steinbild, S., Hedbom, S., Rentschler, J., Kaiser, R., Rouyrre, N., Trommeshauser, D., Hoesl, C. E., and Munzert, G. (2008) Phase I dose escalation and pharmacokinetic study of BI 2536, a novel Polo-like kinase 1 inhibitor, in patients with advanced solid tumors. J. Clin. Oncol. 26, 5511-5517
64. Steegmaier, M., Hoffmann, M., Baum, A., Lénárt, P., Petronczki, M., Krssák, M., Gürtler, U., Garin-Chesa, P., Lieb, S., Quant, J., Grauert, M., Adolf, G. R., Kraut, N., Peters, J. M., and Rettig, W. J. (2007) BI 2536, a potent and selective inhibitor of Polo-like kinase 1, inhibits tumor growth in vivo. Curr. Biol. 17, 316-322